Your shopping cart is currently empty

GPX4-IN-4 (Compound 24) is a potent inhibitor of GPX4, employed in cancer research [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,670 | 8-10 weeks | 8-10 weeks | |
| 50 mg | $2,180 | 8-10 weeks | 8-10 weeks | |
| 100 mg | $2,800 | 8-10 weeks | 8-10 weeks |
| Description | GPX4-IN-4 (Compound 24) is a potent inhibitor of GPX4, employed in cancer research [1]. |
| In vitro | GPX4-IN-4 (Compound 24) reduces HT1080 cell viability in a dose- and time-dependent fashion at concentrations ranging from 0 to 1000 nM and durations up to 24 hours [1]. Similarly, GPX4-IN-4 demonstrates inhibitory effects on NCI-H1703 cell viability over 72 hours, with EC50 values of 0.117 μM without Fer-1 and 4.74 μM with Fer-1 [1]. |
| In vivo | GPX4-IN-4 (Compound 24; 100 and 200 mg/kg; i.p.; once) targets renal GPX4 and induces the expression of PD biomarkers in mice [1]. Despite partial target engagement observed in tumor masses, GPX4-IN-4 (50 mg/kg; i.p.; daily for 20 days) does not affect the growth of WSU-DLCL2 tumors in mice [1]. |
| Molecular Weight | 460.93 |
| Formula | C22H21ClN2O5S |
| Cas No. | 2920221-53-8 |
| Smiles | #N/A |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.